Weekly Recap: Q2 EPS +10% on ~$12B sales and Gibco CHO—K1 launch

Thermo Fisher Scientific Inc. (NYSE:TMO) reported Q2 adjusted EPS of $6.03 on roughly $12B in revenue as management cited broad end-market demand, and its new Gibco CHO—K1 Catalog Panel—cGMP-ready basal and feed media—drove notable performance gains of up to 73% higher titer and 202% higher peak VC…